Abstract
Purpose
Thiolated chitosan appears to possess enhanced mucoadhesiveness and cell penetration properties, however, its potential in gene-drug delivery remains unknown. Herein, we report on a highly effective gene delivery system utilizing a 33-kDa thiol-modified chitosan derivative.
Methods
Thiolated chitosan was prepared by the reaction with thioglycolic acid. Nanocomplexes of unmodified chitosan or thiolated chitosan with plasmid DNA encoding green fluorescenct protein (GFP) were characterized for their size, zeta potential, their ability to bind and protect plasmid DNA from degradation. The transfection efficiency of thiolated chitosan and sustained gene expression were evaluated in various cell lines in vitro and in Balb/c mice in vivo.
Results
Thiolated chitosan–DNA nanocomplexes ranged in size from 75 to 120 nm in diameter and from +2.3 to 19.7 mV in zeta potential, depending on the weight ratio of chitosan to DNA. Thiolated chitosan, CSH360, exhibited effective physical stability and protection against DNase I digestion at a weight ratio ≥ 2.5:1. CSH360/DNA nanocomplexes induced significantly (P < 0.01) higher GFP expression in HEK293, MDCK and Hep-2 cell lines than unmodified chitosan. Nanocomplexes of disulphide-crosslinked CSH360/DNA showed a sustained DNA release and continuous expression in cultured cells lasting up to 60 h post transfection. Also, intranasal administration of crosslinked CSH360/DNA nanocomplexes to mice yielded gene expression that lasted for at least 14 days.
Conclusions
Thiolated chitosans condense pDNA to form nanocomplexes, which exhibit a significantly higher gene transfer potential and sustained gene expression upon crosslinking, indicating their great potential for gene therapy and tissue engineering.
Similar content being viewed by others
References
A. K. Salem, P. C. Searson, and K. W. Leong. Multifunctional nanorods for gene delivery. Nature Materials 2:668–671 (2003).
S. A. Agnihotri, N. N. Mallikarjuna, and T. M. Aminabhavi. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 100:5–28 (2004).
T. Yamada, Y. Iwasaki, H. Tada, H. Iwabuki, M. K. L. Chuah, T. VandenDriessche, H. Fukuda, A. Kondo, M. Ueda, M. Seno, K. Tanizawa, and S. Kuroda. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat. Biotechnol. 21:885–890 (2003).
S. Mansouri, P. Lavigne, K. Corsi, M. Benderdour, E. Beaumont, and J. C. Fernandes. Chitosan–DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm. 57:1–8 (2004).
M. Ravi Kumar, M. Sameti, S. S. Mohapatra, X. Kong, R. F. Lockey, U. Bakowsky, G. Lindenblatt, H. Schmidt, and C. M. Lehr. Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. J. Nanosci. Nanotechnol. 4:876–881 (2004).
G. Hellermann and S. S. Mohapatra. Genetic therapy: on the brink of a new future. Genet. Vaccines Ther. 4:1 (2003).
M. Lee, J. W. Nah, Y. Kwon, J. J. Koh, K. S. Ko, and S. W. Kim. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm. Res. 18:427–431 (2001).
H. Shen, J. Tan, and W. M. Saltzman. Surface-mediated gene transfer from nanocomposites of controlled texture. Nature Materials 3:569–574 (2004).
W. D. Zhang, H. Yang, X. Y. Kong, S. Mohapatra, H. San Juan-Vergara, G. Hellermann, S. Behera, R. Singam, R. F. Lockey, and S. S. Mohapatra. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat. Med. 11:56–62 (2005).
M. Ravi Kumar, S. S. Mohapatra, X. Kong, P. K. Jena, U. Bakowsky, and C. M. Lehr. Cationic poly(lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents. J. Nanosci. Nanotechnol. 4:990–994 (2004).
M. Ravi Kumar, G. Hellermann, R. F. Lockey, and S. S. Mohapatra. Nanoparticle-mediated gene delivery: State of the art. Expert Opin. Biol. Ther. 4:1213–1224 (2004).
M. Kumar, A. K. Behera, R. F. Lockey, J. Zhang, G. Bhullar, C. P. De La Cruz, L. C. Chen, K. W. Leong, S. K. Huang, and S. S. Mohapatra. Intranasal gene transfer by chitosan–DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum. Gene Ther. 13:1415–1425 (2002).
S. S. Mohapatra. Mucosal gene expression vaccine: a novel vaccine strategy for respiratory syncytial virus. Pediatr. Infect. Dis. J. 22:S100–S104 (2003).
M. Kumar, X. Kong, A. K. Behera, G. R. Hellermann, R. F. Lockey, and S. S. Mohapatra. Chitosan IFN-r-pDNA nanoparticle (CIN) therapy for allergic asthma. Genet. Vaccines Ther. 1:1–3 (2003).
Y. C. Wang, S. H. Kao, and H. J. Hsieh. A chemical surface modification of chitosan by glycoconjugates to enhance the cell–biomaterial interaction. Biomacromolecules 4:224–231 (2003).
T. Kiang, H. Wen, H. W. Lim, and K. W. Leong. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 25:5293–5301 (2004).
K. Y. Lee, I. C. Kwon, Y.-H. Kim, W. H. Jo, and S. Y. Jeong. Preparation of chitosan self-aggregates as a gene delivery system. J. Control. Release 51:213–220 (1998).
M. Koping-Hoggard, K. M. Varum, M. Issa, S. Danielsen, B. E. Christensen, B. T. Stokke, and P. Artursson. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 11:1441–1452 (2004).
A. Bernkop-Schnurch, M. Hornof, and T. Zoidl. Thiolated polymers-thiomers: Synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int. J. Pharm. 260:229–237 (2003).
M. Roldo, M. Hornof, P. Caliceti, and A. Bernkop-Schnurch. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur. J. Pharm. Biopharm. 57:115–121 (2004).
C. E. Kastand A. Bernkop-Schnurch. Thiolated polymers–thiomers: development and in vitro evaluation of chitosan–thioglycolic acid conjugates. Biomaterials 22:2345–2352 (2001).
H. K. N. Langoth, G. Schoffmann, I. Schmerold, M. Schuh, S. Franz, P. Kurka, and A. Bernkop-Schnurch. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system. Pharm. Res. 23:573–579 (2006).
P. He, S. S. Davis, and L. Illum. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166:75–88 (1998).
A. Bernkop-Schnurch, C. E. Kast, and D. Guggi. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J. Control. Release 93:95–103 (2003).
A. Bernkop-Schnurch, D. Guggi, and Y. Pinter. Thiolated chitosans: Development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Control. Release 94:177–186 (2004).
A. Bernkop-Schnurch, M. Hornof, and D. Guggi. Thiolated chitosans. Eur. J. Pharm. Biopharm. 57:9–17 (2004).
T. Cerchiara, B. Luppi, F. Bigucci, and V. Zecchi. Chitosan salts as nasal sustained delivery systems for peptidic drugs. J. Pharm. Pharmacol. 55:1623–1627 (2003).
D. W. Lee and R. H. Baney. Oligochitosan derivatives bearing electron-deficient aromatic rings for adsorption of amitriptyline: implications for drug detoxification. Biomacromolecules 5:1310–1315 (2004).
T. Sato, T. Ishii, and Y. Okahata. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22:2075–2080 (2001).
T. Ishii, Y. Okahata, and T. Sato. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta, Biomembr. 1514:51–64 (2001).
A. V. Ii’inaand V. P. Varlamov. Chitosan-based polyelectrolyte complexes: a review. Appl. Biochem. Microbiol. 41:5–11 (2005).
N. Fang, V. Chan, H. Q. Mao, and K. W. Leong. Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules 2:1161–1168 (2001).
L. D. Shea, E. Smiley, J. Bonadio, and D. J. Mooney. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17:551–554 (1999).
F. Scherer, U. Schillinger, U. Putz, A. Stemberger, and C. Plank. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J. Gene Med. 4:634–643 (2002).
B. D. Klugherz, P. L. Jones, X. M. Cui, W. L. Chen, N. F. Meneveau, S. DeFelice, J. Connolly, R. L. Wilensky, and R. J. Levy. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat. Biotechnol. 18:1181–1184 (2000).
H. Cohen, R. J. Levy, J. Gao, I. Fishbein, V. Kousaev, S. Sosnowski, S. Slomkowski, and G. Golomb. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7:1896–1905 (2000).
H. Shen, E. Goldberg, and W. M. Saltzman. Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix. J. Control. Release 86:339–348 (2003).
V. L. Truong-Le, J. T. August, and K. W. Leong. Controlled gene delivery by DNA-gelatin nanospheres. Hum. Gene Ther. 9:1709–1717 (1998).
K. W. Chun, J. B. Lee, S. H. Kim, and T. G. Park. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials 26:3319–3326 (2005).
M. L. Lorenzo-Lamosa, C. Remunan-Lopez, J. L. Vila-Jato, and M. J. Alonso. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Release 52:109–118 (1998).
Y. H. Yun, D. J. Goetz, P. Yellen, and W. L. Chen. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 25:147–157 (2004).
D. Luo and W. M. Saltzman. Synthetic DNA delivery systems. Nat. Biotechnol. 18:33–37 (2000).
M. Koping-Hoggard, I. Tubulekas, H. Guan, K. Edwards, M. Nilsson, K. M. Varum, and P. Artursson. Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. 8:1108–1121 (2001).
Acknowledgment
This work was supported by NIH (5RO1HL71101-01A2) awarded to SSM and Culverhouse Endowment to the Division of Allergy and Immunology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, D., Zhang, W., Shirley, S.A. et al. Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery. Pharm Res 24, 157–167 (2007). https://doi.org/10.1007/s11095-006-9136-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9136-9